Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report-Reference-Cited by-同舟云学术

Development of hypocomplementemic urticarial vasculitis during certolizumab pegol treatment for rheumatoid arthritis: A case report

Published:2020-01-28 Issue:5 Volume:45 Page:1179-1182
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Horai Yoshiro¹²^ORCID,Ishikawa Hiroshi³,Iwanaga Nozomi¹,Izumi Yasumori⁴,Matsuoka Yuki⁵,Miura Shiro⁵,Kawakami Atsushi⁶

Affiliation:

1. Department of Rheumatology National Hospital Organization Nagasaki Medical Center Omura Japan

2. Clinical Research Center National Hospital Organization Nagasaki Medical Center Omura Japan

3. Department of Dermatology National Hospital Organization Nagasaki Medical Center Nagasaki Japan

4. Department of General Internal Medicine National Hospital Organization Nagasaki Medical Center Omura Japan

5. Department of Pathology National Hospital Organization Nagasaki Medical Center Nagasaki Japan

6. Division of Advanced Preventive Medical Sciences Department of Immunology and Rheumatology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13117

Reference19 articles.

1. Cutaneous vasculitis induced by TNF inhibitors: a report of three cases

2. Autoimmune Diseases Induced by TNF-Targeted Therapies

3. Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety

4. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

5. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Successful Subcutaneous Desensitization to Certolizumab Pegol;Journal of Investigational Allergology and Clinical Immunology;2024-07-30

2. Cutaneous immune-related phenomena in patients with inflammatory arthritides treated with biological therapies: Clinical and pathophysiological considerations;Seminars in Arthritis and Rheumatism;2023-12

3. Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System;Drug Safety;2023-02-15

4. Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: A case report;Modern Rheumatology Case Reports;2023-01-25

5. Cutaneous vasculitis associated with molecular tergeted therapies: systematic review of the literature;Clinical Rheumatology;2022-11-12